Technical Requirements for Clinical Development of Overseas-marketed and Domestic-non-marketed Products

On 12 October 2020 the Chinese CDE of NMPA issued notification No. 29 on technical requirements.

The guideline applies to clinical development considerations for overseas-marketed and domestic-non-marketed reference products as well as generics. The clinical evaluation rationale covered in the guideline is based on clinical needs assessment, efficacy and safety evaluation and clinical trial requirement.

Read more online 
Copyright Widler & Schiemann AG 2022. All Rights Reserved. /